Neuropsychopharmacology
- Transcription factors Lef1 and Rest stimulate recovery from depressive states11 months ago
- Early-life neural correlates of behavioral inhibition and anxiety risk11 months ago
- In Memoriam Peter Charles Whybrow, M.D., D.P.M., M.B., F.R.C.P11 months ago
- Preclinical efficacy of the muscarinic agonist ML-007 in psychosis models depends on both M1 and M4 receptors11 months ago
- The genetics of cannabis lifetime use12 months ago
- Transdiagnostic prevention in youth mental health, Part I: rationale, shared risk factors12 months ago
- Inflammatory mechanisms contribute to long-term cognitive deficits induced by perinatal asphyxia via interleukin-112 months ago
Journal of Psychopharmacology
- Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials2 years ago
- Into the wild frontier: Mapping the terrain of adverse events in psychedelic-assisted therapies2 years ago
- Co-use of psychedelics with other substances: Findings from the global psychedelic survey2 years ago
- Effects of positive mGlu5 modulation on D2 signaling and nicotine-conditioned place preference: Mechanisms of epigenetic inheritance in a transgenerational model of drug abuse vulnerability in psychosis2 years ago
- Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment2 years ago
- The impact of cannabidiol placebo on amygdala-based neural responses to an acute stressor2 years ago
- Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm2 years ago
European Neuropsychopharmacology
- Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research2 years ago
- The Transdiagnostic Global Impression – Psychopathology scale (TGI-P): Initial development of a novel transdiagnostic tool for assessing, tracking, and visualising psychiatric symptom severity in everyday practice2 years ago
- The gut-microbiome in adult Attention-deficit/hyperactivity disorder – A Meta-analysis2 years ago
- Effects of antipsychotic treatment on cardio-cerebrovascular related mortality in schizophrenia: A subanalysis of a systematic review and meta-analysis with meta-regression of moderators2 years ago
- The role of biomarkers in clinical development of drugs for neuropsychiatric disorders – A pragmatic guide2 years ago
- GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review2 years ago
- Treatment or enhancement? The controversial role of medication in personality disorders2 years ago